Amedeo Smart

Free Medical Literature Service



Alzheimer's Disease

  Free Subscription


1 Alzheimers Dement
1 Am J Alzheimers Dis Other Demen
1 BMC Neurosci
1 Dement Geriatr Cogn Disord
18 J Alzheimers Dis
1 J Neurol Neurosurg Psychiatry
1 Nat Rev Neurol
2 Neurobiol Aging
3 Neurochem Res
1 Neurologia (Engl Ed)
2 Neurology
1 Neurosci Lett
1 PLoS Biol
1 PLoS Genet

    Alzheimers Dement

  1. PHILLIPS JS, Nitchie FJ 4th, Da Re F, Olm CA, et al
    Rates of longitudinal change in (18) F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease.
    Alzheimers Dement. 2021 Sep 13. doi: 10.1002/alz.12456.
    >> Share

    Am J Alzheimers Dis Other Demen

  2. HENDRIKS I, Demetrio R, Meiland FJM, Chattat R, et al
    Value of Personalized Dementia-Specific Quality of Life Scales: An Explorative Study in 3 European Countries.
    Am J Alzheimers Dis Other Demen. 2021;36:15333175211033721.
    >> Share

    BMC Neurosci

  3. WEN J, Zhao M, Sun W, Cheng X, et al
    Uptake of Abeta by OATPs might be a new pathophysiological mechanism of Alzheimer disease.
    BMC Neurosci. 2021;22:53.
    >> Share

    Dement Geriatr Cogn Disord

  4. HONG YJ, Han HJ, Youn YC, Park KW, et al
    Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial.
    Dement Geriatr Cogn Disord. 2021 Sep 10:1-7. doi: 10.1159/000518470.
    >> Share

    J Alzheimers Dis

  5. EDLUND AK, Chen K, Lee W, Protas H, et al
    Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3/varepsilon4 Carriers.
    J Alzheimers Dis. 2021;81:339-354.
    >> Share

  6. UMEGAKI H, Suzuki Y, Komiya H, Watanabe K, et al
    Frequencies and Neuropsychological Characteristics of Errors in the Clock Drawing Test.
    J Alzheimers Dis. 2021;82:1291-1300.
    >> Share

  7. GONZALEZ-ALCAIDE G, Fernandez-Rios M, Redolat R, Serra E, et al
    Research on Emotion Recognition and Dementias: Foundations and Prospects.
    J Alzheimers Dis. 2021;82:939-950.
    >> Share

  8. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    The Free and Cued Selective Reminding Test Predicts Braak Stage.
    J Alzheimers Dis. 2021;80:175-183.
    >> Share

  9. STONNINGTON CM, Wu J, Zhang J, Shi J, et al
    Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
    J Alzheimers Dis. 2021;81:209-220.
    >> Share

  10. RHODES E, Insel PS, Butters MA, Morin R, et al
    The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
    J Alzheimers Dis. 2021;80:991-1002.
    >> Share

  11. PEIRA E, Grazzini M, Bauckneht M, Sensi F, et al
    Probing the Role of a Regional Quantitative Assessment of Amyloid PET.
    J Alzheimers Dis. 2021;80:383-396.
    >> Share

  12. LI X, Shen M, Jin Y, Jia S, et al
    Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
    J Alzheimers Dis. 2021;80:371-381.
    >> Share

  13. SATO K, Mano T, Iwata A, Toda T, et al
    Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
    J Alzheimers Dis. 2021;82:1333-1344.
    >> Share

  14. WERBER T, Bata Z, Vaszine ES, Berente DB, et al
    The Association of Periodontitis and Alzheimer's Disease: How to Hit Two Birds with One Stone.
    J Alzheimers Dis. 2021 Sep 8. pii: JAD210491. doi: 10.3233/JAD-210491.
    >> Share

  15. COLATO E, Chiotis K, Ferreira D, Mazrina MS, et al
    Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210614. doi: 10.3233/JAD-210614.
    >> Share

  16. SRIWICHAIIN S, Chattipakorn N, Chattipakorn SC
    Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210737. doi: 10.3233/JAD-210737.
    >> Share

  17. DENNISON JL, Ricciardi NR, Lohse I, Volmar CH, et al
    Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
    J Alzheimers Dis. 2021;80:41-52.
    >> Share

  18. GNANAPRAKASH M, Staniszewski A, Zhang H, Pitstick R, et al
    Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
    J Alzheimers Dis. 2021;79:1813-1829.
    >> Share

  19. MARTINEZ-MALDONADO A, Ontiveros-Torres MA, Harrington CR, Montiel-Sosa JF, et al
    Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    J Alzheimers Dis. 2021;79:1517-1531.
    >> Share

  20. BASCUNANA P, Brackhan M, Pahnke J
    Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-beta Deposits and Activated Microglia.
    J Alzheimers Dis. 2021;79:597-605.
    >> Share

  21. BERGER M, Cooter M, Roesler AS, Chung S, et al
    APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.
    J Alzheimers Dis. 2021;79:511-530.
    >> Share

  22. COSTA AS, Pinho J, Kucikiene D, Reich A, et al
    Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    J Alzheimers Dis. 2021;79:1661-1672.
    >> Share

    J Neurol Neurosurg Psychiatry

  23. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    >> Share

    Nat Rev Neurol

  24. BETTCHER BM, Tansey MG, Dorothee G, Heneka MT, et al
    Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.
    Nat Rev Neurol. 2021 Sep 14. pii: 10.1038/s41582-021-00549.
    >> Share

    Neurobiol Aging

  25. SHEPHERD A, Lim JKH, Wong VHY, Zeleznikow-Johnston AM, et al
    Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing.
    Neurobiol Aging. 2021;108:58-71.
    >> Share

  26. PALIWAL D, McInerney TW, Pa J, Swerdlow RH, et al
    Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease.
    Neurobiol Aging. 2021 Aug 18. pii: S0197-4580(21)00259.
    >> Share

    Neurochem Res

  27. WAN T, Fu M, Jiang Y, Jiang W, et al
    Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.
    Neurochem Res. 2021 Sep 13. pii: 10.1007/s11064-021-03448.
    >> Share

  28. CAO B, Zeng M, Zhang Q, Zhang B, et al
    Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Abeta25-35-Induced Mice by mTOR Signaling.
    Neurochem Res. 2021;46:921-934.
    >> Share

  29. HACIOGLU C, Kar F, Kanbak G
    Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protective Agent on Rat Synaptosomes Treated with Abeta(1-42).
    Neurochem Res. 2021;46:804-818.
    >> Share

    Neurologia (Engl Ed)

  30. BELLO-MEDINA PC, Gonzalez-Franco DA, Vargas-Rodriguez I, Diaz-Cintra S, et al
    Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.
    Neurologia (Engl Ed). 2021 Sep 8. pii: S2173-5808(21)00131.
    >> Share


  31. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    >> Share

  32. BUCIUC M, Josephs KA, Jones DT, Whitwell JL, et al
    Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012783.
    >> Share

    Neurosci Lett

  33. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    >> Share

    PLoS Biol

  34. LAM V, Takechi R, Hackett MJ, Francis R, et al
    Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype.
    PLoS Biol. 2021;19:e3001358.
    >> Share

    PLoS Genet

  35. ZHAN L, Li J, Jew B, Sul JH, et al
    Rare variants in the endocytic pathway are associated with Alzheimer's disease, its related phenotypes, and functional consequences.
    PLoS Genet. 2021;17:e1009772.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016